Silk-Based Therapeutics Targeting Pseudomonas aeruginosa
Source abstract
Abstract
Pseudomonas aeruginosa (P. aeruginosa) infections may lead to severe damage of the cornea, mucosa, and skin. The highly aggressive nature of P. aeruginosa and the rise in multi-drug resistance, particularly in nosocomial settings, lead to an increased risk for permanent tissue damage and potentially death. Thus, a growing need exists to develop alternative treatments to reduce both the occurrence of bacterial infection and biofilm development, as well as pathological progression post-infection. Silk derived from Bombyx mori silkworms serves as a unique biomaterial that is biocompatible with low immunogenicity and high versatility, and thereby ideal for stabilizing therapeutics. In this study, we assessed the cytotoxicity of P. aeruginosa on human corneal stromal stem cells and two mucosal cell lines (Caco-2 and HT29-MTX). To determine whether antibiotic-immobilized scaffolds can serve as alternative therapeutics to free, diffuse forms, we developed novel gentamicin-conjugated silk films as functional scaffolds and compared antimicrobial effects and free gentamicin. The advantages of generating a surface coating with a covalently-bound antibiotic may reduce potential side-effects associated with free gentamicin, as well as limit the diffusion of the drug. Our results suggest that gentamicin conjugated to native silk and carboxyl-enriched silk inhibits P. aeruginosa growth. Development of stabilized antibiotic treatments with surface toxicity selective against bacteria may serve as an alternative approach to treat active infections, as well as potential prophylactic use as coatings in high-risk cases, such as post-surgical complications or prolonged hospitalization.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Silk-based biomaterials and applications · Antimicrobial Peptides and Activities · Biochemical and Structural Characterization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedical Engineering, Tufts University, 4 Colby St, Medford, MA 02155, USA
Funding
National Institutes of Health
References (46)
Show source-provided references
1. Establishment of Pseudomonas aeruginosa infection: Lessons from a versatile opportunist10.1016/S1286-4579(00)01259-4 ↗
2. CDC (2013, April 23). Antibiotic resistance threats in the United States, 2013 Services, US Department of Health and Human Services, Ed, Available online: https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.
3. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients10.1073/pnas.0602138103 ↗
4. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection10.1126/science.288.5469.1251 ↗
5. 2007 guideline for isolation precautions: Preventing transmission of infectious agents in health care settings10.1016/j.ajic.2007.10.007 ↗
6. Structural origins of gentamicin antibiotic action10.1093/emboj/17.22.6437 ↗
7. Surface action of gentamicin on Pseudomonas aeruginosa10.1128/jb.175.18.5798-5805.1993 ↗
8. Development of gentamicin-gold nanospheres for antimicrobial drug delivery to staphylococcal infected foci10.3109/10717544.2012.746402 ↗
9. On the enhanced antibacterial activity of antibiotics mixed with gold nanoparticles10.1007/s11671-009-9316-8 ↗
10. Quantitation of slow drug release from an implantable and degradable gentamicin conjugate by in vivo magnetic resonance imaging10.1128/AAC.39.4.839 ↗
11. Tunable antimicrobial polypropylene surfaces: Simultaneous attachment of penicillin (gram+) and gentamicin (gram−)10.1021/bm8013473 ↗
12. Interaction of gentamicin with the a band and b band lipopolysaccharides of Pseudomonas aeruginosa and its possible lethal effect10.1128/AAC.37.4.715 ↗
13. Aminoglycosides: Perspectives on mechanisms of action and resistance and strategies to counter resistance10.1128/AAC.44.12.3249-3256.2000 ↗
14. Vancomycin covalently bonded to titanium alloy prevents bacterial colonization10.1002/jor.20348 ↗
15. Vancomycin covalently bonded to titanium beads kills staphylococcus aureus10.1016/j.chembiol.2005.06.013 ↗
16. Synthesis and characterization of an antibacterial hydrogel containing covalently bound vancomycin10.1021/bm5006323 ↗
17. Covalent immobilization of antimicrobial peptides (amps) onto biomaterial surfaces10.1016/j.actbio.2010.11.005 ↗
18. Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin10.1128/AAC.39.2.301 ↗
19. Antimicrobial peptides: Linking partition, activity and high membrane-bound concentrations10.1038/nrmicro2095 ↗
20. Silk-based biomaterials for sustained drug delivery10.1016/j.jconrel.2014.05.059 ↗
21. Silk as a biomaterial to support long-term three-dimensional tissue cultures10.1021/acsami.5b12114 ↗
22. Silk fibroin biomaterials for controlled release drug delivery10.1517/17425247.2011.568936 ↗
23. Materials fabrication from bombyx mori silk fibroin10.1038/nprot.2011.379 ↗
24. Degradation of silk films in multipocket corneal stromal rabbit models
25. Silk film biomaterials for cornea tissue engineering10.1016/j.biomaterials.2008.11.018 ↗
26. Corneal stromal bioequivalents secreted on patterned silk substrates10.1016/j.biomaterials.2013.12.078 ↗
27. Antibiotic-releasing silk biomaterials for infection prevention and treatment10.1002/adfm.201201636 ↗
28. Silk hydrogels for sustained ocular delivery of anti-vascular endothelial growth factor (anti-vegf) therapeutics10.1016/j.ejpb.2014.12.029 ↗
29. Gentamicin toxicity in the primate retina10.1001/archopht.1989.01070010109037 ↗
30. Gentamicin vestibulotoxicity10.1177/019459989411100506 ↗
31. Pseudomonas aeruginosa: Resistance and therapeutic options at the turn of the new millennium10.1111/j.1469-0691.2007.01681.x ↗
32. Antibiotic resistance of bacteria in biofilms10.1016/S0140-6736(01)05321-1 ↗
33. Biomedical applications of chemically-modified silk fibroin10.1039/b905802h ↗
34. Ph sensitive ionomeric particles obtained via chemical conjugation of silk with poly-amino acids10.1021/bm100925s ↗
35. Molecular and macro-scale analysis of enzyme-crosslinked silk hydrogels for rational biomaterial design10.1016/j.actbio.2017.09.020 ↗
36. Analytical method for the determination of the aminoglycoside gentamicin in hospital wastewater via liquid chromatography–electrospray-tandem mass spectrometry10.1016/S0021-9673(03)00059-1 ↗
37. Barbier, M., and Mittar, D. (2014). Novel Fluorescent Reporters for Studying Host-Pathogen Interactions, American Type Culture Collection (ATCC).
38. Regulation of silk material structure by temperature-controlled water vapor annealing10.1021/bm200062a ↗
39. Accelerated in vitro degradation of optically clear low beta-sheet silk films by enzyme-mediated pretreatment10.1167/tvst.2.3.2 ↗
40. The human colon carcinoma cell lines ht-29 and caco-2: Two in vitro models for the study of intestinal differentiation10.1016/S0300-9084(86)80177-8 ↗
41. Differential expression of the human mucin genes muc1 to muc5 in relation to growth and differentiation of different mucus-secreting ht-29 cell subpopulations10.1242/jcs.106.3.771 ↗
42. Response of human corneal fibroblasts on silk film surface patterns10.1002/mabi.200900452 ↗
43. Human limbal biopsy-derived stromal stem cells prevent corneal scarring10.1126/scitranslmed.3009644 ↗
44. Nih image to imagej: 25 years of image analysis10.1038/nmeth.2089 ↗
45. Aligned silk-based 3-d architectures for contact guidance in tissue engineering10.1016/j.actbio.2011.12.015 ↗
46. Pathogenesis of contact lens-associated microbial keratitis10.1097/OPX.0b013e3181d408ee ↗